Market Tracker

01/20 5:16pm ET

Bio Rad Laboratories Inc (NYSE:BIO)

186.91
Delayed Data
As of Jan 20
 -0.52 / -0.28%
Today’s Change
122.03
Today|||52-Week Range
194.20
+2.54%
Year-to-Date
Will 2017 Be Illumina's Best Year Yet?
Jan 13 / MotleyFool.com - Paid Partner Content
Illumina Stock Upgraded: What You Need to Know
Jan 10 / MotleyFool.com - Paid Partner Content
Here's Why Illumina Is Soaring Today
Jan 10 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close187.43
Today’s open188.12
Day’s range186.48 - 188.58
Volume154,318
Average volume (3 months)164,300
Market cap$4.6B
Dividend yield--
Data as of 4:02pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)+26.23%
Earnings growth (this year)-28.31%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)-7.15%
P/E ratio56.1
Price/Sales2.02
Price/Book2.21

Competitors

 Today’s
change
Today’s
% change
BRKRBruker Corp-0.27-1.20%
PKIPerkinElmer Inc-0.41-0.79%
QGENQiagen NV-0.05-0.18%
AXDXAccelerate Diagnosti...-0.90-4.22%
Data as of 4:02pm ET, 01/20/2017

Financials

Next reporting dateFebruary 24, 2017
EPS forecast (this quarter)$1.11
Annual revenue (last year)$2.0B
Annual profit (last year)$113.1M
Net profit margin5.60%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Norman D. Schwartz
Chief Operating Officer &
Executive Vice President
John Goetz
Corporate headquarters
Hercules, California

Forecasts